Serum ESPL1 Protein as an Early Warning Biomarker for the Initial Occurrence and Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma

Author:

Hu Bobin1,Deng Deli1,Liang Hengkai1,Wang Rongming1,Su Minghua1,Wei Lu1,Su Tumei1,Li Qingmei1,Yin Qianbing1,Feng Yanfei1,Jiang Jianning1

Affiliation:

1. The First Affiliated Hospital of Guangxi Medical University

Abstract

Abstract Aim This study aims to assess the potential of serum Extra Spindle Pole Bodies-like 1 (ESPL1) protein as a biomarker for the effective early warning of Hepatitis B Virus (HBV)-related hepatocellular carcinoma (HCC). Methods A cross-sectional study was conducted, including 119 patients who were classified into three groups: chronic hepatitis B (CHB), HBV-related liver cirrhosis (LC), and HBV-HCC. Additionally, a longitudinal study included 49 patients in a non-recurrent (N-Rec) group with first occurrence of HBV-HCC and a recurrent (Rec) group with multiple HCC recurrences. Serum ESPL1 levels were measured using enzyme-linked immunosorbent assay. Differences in serum ESPL1 levels among the CHB, HBV-LC, and HBV-HCC groups and alpha-fetoprotein (AFP) levels among these groups were compared. The dynamic changes of serum ESPL1 and AFP levels were analyzed in the N-Rec group before and after the hepatectomy and in the Rec group before and after each HCC recurrence. Results Serum ESPL1 levels showed a gradual increase in the CHB, HBV-LC, and HBV-HCC groups (P<0.05). In the N-Rec group, serum ESPL1 levels exhibited a continuous upward trend in the 5 years before the hepatectomy, followed by a consistent decline over the subsequent 5 years. In the Rec group, serum ESPL1 levels demonstrated a fluctuating pattern of increase and decrease before and after each liver cancer resection. Conversely, the changes in serum AFP levels did not follow a consistent pattern. Conclusion Serum ESPL1 has potential as a biomarker for effective early warning of initial and recurrent HBV-related HCC.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3